Neogen (NEOG) Change in Accured Expenses (2010 - 2026)
Neogen's (NEOG) quarterly Change in Accured Expenses came in at -$7.5 million in Q1 2026, down 227.93% year-on-year from $5.9 million in Q1 2025, and down 201.06% quarter-over-quarter from $7.5 million in Q4 2025.
Neogen (NEOG) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Neogen's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$7.5 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 227.93% year-over-year to -$7.5 million in Q1 2026; TTM through Feb 2026 was -$14.0 million, a 150.99% decrease from a year earlier, with the FY2025 full-year figure at -$402000.0, down 102.92% from the prior year.
- Change in Accured Expenses retreated to -$7.5 million in Q1 2026 per NEOG's latest filing, from $7.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $24.1 million in Q4 2022 and bottomed at -$20.7 million in Q1 2023.
- The 5-year median for Change in Accured Expenses is -$82000.0 (2023), against an average of $872625.0.
- Across the five-year window, Change in Accured Expenses slumped 486.9% in 2022 and jumped 410.79% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $24.1 million in 2022, then tumbled by 121.34% to -$5.1 million in 2023, then soared by 410.79% to $16.0 million in 2024, then slumped by 53.33% to $7.5 million in 2025, then tumbled by 201.06% to -$7.5 million in 2026.
- Per Business Quant, the three latest NEOG Change in Accured Expenses figures stand at -$7.5 million (Q1 2026), $7.5 million (Q4 2025), and -$7.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Neogen | 2.08 Bn | 1.92 Bn | 99.00 Mn | -7.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7.54 Mn |
| Feb 28, 2026 | -7.54 Mn |
| Nov 30, 2025 | 7.46 Mn |
| Nov 30, 2025 | 7.46 Mn |
| Aug 31, 2025 | -7.52 Mn |
| Aug 31, 2025 | -7.52 Mn |
| May 31, 2025 | -6.40 Mn |
| May 31, 2025 | -6.40 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Nov 30, 2024 | 15.99 Mn |
| Nov 30, 2024 | 15.99 Mn |
| Aug 31, 2024 | -15.88 Mn |
| Aug 31, 2024 | -15.88 Mn |
| May 31, 2024 | 21.46 Mn |
| May 31, 2024 | 21.46 Mn |
| Feb 29, 2024 | -7.55 Mn |
| Feb 29, 2024 | -7.55 Mn |
| Nov 30, 2023 | -5.14 Mn |
| Nov 30, 2023 | -5.14 Mn |